Article
Circulating levels of epirubicin cause endothelial senescence while compromising metabolic activity and vascular function
2020-06-26
Abstract excerpt
Anthracycline-based chemotherapy is a common treatment for cancer patients. Because it is delivered intravenously, endothelial cells are exposed first and to the highest concentrations, prior to diffusion to target cells. Not surprisingly, vascular dysfunction is a consequence of anthracycline therapy. While chemotherapy-induced endothelial damage at administration sites has been investigated, the effects of lower...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1e990393-f7e8-54c3-9fb4-a5fec0e6e905
- DOI
- 10.1101/2020.06.25.171249
